Notify me when GordonMD Global Investments LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | Common Stock, par value $0.00001 per share | 7% | $23,275,071 | 3,058,485 | GordonMD Global Investments LP | 13 Nov 2025 | ||
| PYXS | Pyxis Oncology, Inc. | Common Stock, par value $0.001 per share | 6.2% | $5,330,289 | 3,834,740 | GordonMD Global Investments LP | 14 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|